Richard Oram

Professor Richard Oram is a faculty member at the University of Exeter, affiliated with the NIHR Exeter Clinical Research Facility in the UK. His research focuses on Type 1 diabetes, beta cell function, and polygenic risk scores in autoimmune diseases.

• PhD in Type 1 diabetes research
• BMBCh (Bachelor of Medicine, Bachelor of Surgery)
• BA(hons) in biomedical sciences
• MRCP (Member of the Royal College of Physicians)

Oram's work includes developing a T1D genetic risk score (T1D GRS) to differentiate Type 1 and Type 2 diabetes, collaborating with international institutions like King's College London, the University of Alberta, and the University of Pune. He investigates persistent beta cell function in Type 1 diabetes and its impact on complications like hypoglycemia, while also studying rare early-onset subtypes.

His research integrates genetics and longitudinal biomarkers to predict autoimmune diseases from birth (TEDDY study) and prevent childhood diabetic ketoacidosis (CASCADE study). He has contributed to methods like the Beta2 Score for assessing graft function post-islet transplantation.

• Harry Keen Fellowship
• Funding from JDRF, Diabetes UK, Helmsley Charitable Trust, and NIH

Oram collaborates closely with researchers such as Mike Weedon, Bill Hagopian, Tim Tree, and Andrew Hattersley, advancing genetic risk assessment in ethnically diverse populations. His work spans clinical sciences, epidemiology, and immunology, with applications in public health and biochemistry.